The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.
Information
- Show
- Published13 July 2014 at 19:00 UTC
- Length7 min
- RatingClean